$NVO I was told Lilly’s retatrutide was a game changer that would destroy Novo and render Wegovy and Cagrisema useless . Phase 3 numbers today look awfully “fine” to me at 20-22%. I was expecting 28 to 30% weight loss, like they had previously published. Maybe I’m missing something but this seems like a big positive for Novo
在 X 查看 ↗